Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Maxillary Neoplasms

paclitaxel has been researched along with Maxillary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujieda, S; Imoto, Y; Ito, Y; Kimura, Y; Matsumoto, H; Narita, N; Ogi, K; Takahashi, N; Tanaka, T; Tsuzuki, H; Yamada, T1
Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X1

Other Studies

2 other study(ies) available for paclitaxel and Maxillary Neoplasms

ArticleYear
Suppression of histone deacetylase 3 (HDAC3) enhances apoptosis induced by paclitaxel in human maxillary cancer cells in vitro and in vivo.
    Biochemical and biophysical research communications, 2010, May-28, Volume: 396, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Histone Deacetylases; Humans; Maxillary Neoplasms; Mice; Paclitaxel; Tubulin Modulators; Xenograft Model Antitumor Assays

2010
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
    Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2002, Volume: 37, Issue:6

    Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine

2002